drugset / Trial / NCT00159965

Treatments for Psychogenic Nonepileptic Seizures (NES)

NCT00159965

RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators propose that treatment of the comorbid disorders (depression, anxiety, and impulsivity) with sertraline in patients with lone psychogenic nonepileptic seizures (NES), will result in a decreased number of NES. The purpose of this study is to provide pilot testing and data to inform the future randomized controlled trial based on the hypothesis.

Timeline

Start
2003-12
Primary completion
2008-06
Completion
2009-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule 200 mg